Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.
[familial hypocalciuric hypercalcemia]
The
seven
-spanning
calcium-sensing
receptor
(
CaSR
)
activates
multiple
G
proteins
including
Gq
and
Gi
,
and
thereby
activates
a
variety
of
second
messengers
and
inhibits
parathyroid
hormone
(
PTH
)
secretion
.
However
,
the
exact
signaling
mechanisms
underlying
the
functional
activity
of
CaSR
are
not
yet
fully
understood
.
The
heterozygous
inactivation
of
CaSR
or
its
inhibition
by
antibody
blocking
results
in
either
familial
hypocalciuric
hypercalcemia
or
acquired
hypocalciuric
hypercalcemia
(
AHH
)
,
respectively
.
Here
,
we
report
the
identification
of
a
unique
CaSR
autoantibody
in
an
AHH
patient
.
Paradoxically
,
we
find
that
this
autoantibody
potentiates
the
Ca
(
2
+
)
/
Gq-dependent
accumulation
of
inositol
phosphates
by
slightly
shifting
the
dose
dependence
curve
of
the
Ca
(
2
+
)
mediated
activation
of
phosphatidylinositol
turnover
to
the
left
,
whereas
it
inhibits
the
Ca
(
2
+
)
/
Gi
-dependent
phosphorylation
of
ERK
1
/
2
in
HEK
293
cells
stably
expressing
human
CaSR
.
Treatment
of
these
same
cells
with
a
calcimimetic
,
NPS
-R-
568
,
augments
the
CaSR
response
to
Ca
(
2
+
)
,
increasing
phosphatidylinositol
turnover
and
ERK
1
/
2
phosphorylation
,
and
overcoming
the
autoantibody
effects
.
Our
observations
thus
indicate
that
a
calcium
-stimulated
CaSR
primed
by
a
specific
autoantibody
adopts
a
unique
conformation
that
activates
Gq
but
not
Gi
.
Our
findings
also
suggest
that
CaSR
signaling
may
act
via
both
Gq
and
Gi
to
inhibit
PTH
secretion
.
This
is
the
first
report
of
a
disease-related
autoantibody
that
functions
as
an
allosteric
modulator
and
maintains
G
protein-coupled
receptors
(
GPCRs
)
in
a
unique
active
conformation
with
its
agonist
.
We
thus
speculate
that
physiological
modulators
may
exist
that
enable
an
agonist
to
specifically
activate
only
one
signaling
pathway
via
a
GPCR
that
activates
multiple
signaling
pathways
.
Diseases
Validation
Diseases presenting
"hypercalcemia"
symptom
carcinoma of the gallbladder
cushing syndrome
familial hypocalciuric hypercalcemia
kabuki syndrome
severe combined immunodeficiency
waldenström macroglobulinemia
This symptom has already been validated